APA (7th ed.) Citation

Dimou, A., Ou, S. I., & Doebele, R. C. (2019). Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation. JCO Precision Oncology, 3, 1. https://doi.org/10.1200/PO.19.00013

Chicago Style (17th ed.) Citation

Dimou, Anastasios, Sai-Hong I. Ou, and Robert C. Doebele. "Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation." JCO Precision Oncology 3 (2019): 1. https://doi.org/10.1200/PO.19.00013.

MLA (9th ed.) Citation

Dimou, Anastasios, et al. "Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation." JCO Precision Oncology, vol. 3, 2019, p. 1, https://doi.org/10.1200/PO.19.00013.